BioFlyte is a biodefense company created to commercialize a revolutionary new class of fieldable biological threat collection, detection, and identification solutions.
BioFlyte is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats.
BioFlyte was founded in 2020 by Charles Call. The company is headquartered in Albuquerque, New Mexico.
BioFlyte's first product is the z750 handheld collector, designed to provide CBRN Defense Forces and Emergency Response Teams with an advanced high-performance handheld aerosol sampler. The z750 handheld collector is designed around a proven dry filter technology that has been in use worldwide for decades.
The BioFlyte™ z200 is a breakthrough combination collector/detector/identifier system that uses matrix-assisted laser desorption and ionization (MALDI) mass spectrometry to acquire a mass spectrum from the collected aerosol sample.
BioFlyte has raised $1.25M in Seed round of funding on June 09, 2020. This seed stage equity financing round was led by venture capital firm Anzu Partners.